Medicine
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Dong Yang
2008.7.28Chinese Journal of Neurosurgery
tlooto Summary
The RT-TMZ Group was well in local control rate, delaying relapse and increasing relapse free survival rate compared with RT Group, and the side-effect were little in both groups.
Abstract
Abstract is not available.
Citation format
YANG, Dong. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Chinese Journal of Neurosurgery, 2008, 24: 487–489.